We are live on ! Find out more
MC

Muhlenkamp & Co Portfolio holdings

AUM $345M
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+6.46%
1 Year Est. Return
+34.25%
3 Year Est. Return
+107.36%
5 Year Est. Return
10 Year Est. Return
AUM
$338M
AUM Growth
+$20.9M
Cap. Flow
+$6.21M
Cap. Flow %
1.83%
Top 10 Hldgs %
47.23%
Holding
80
New
5
Increased
6
Reduced
42
Closed
7

Top Buys

Rank Stock Value
1
PHM icon
Pultegroup
PHM
+$6.22M
2
THO icon
Thor Industries
THO
+$6.05M
3
AZO icon
AutoZone
AZO
+$4.33M
4
EPD icon
Enterprise Products Partners
EPD
+$423K
5
CE icon
Celanese
CE
+$57.9K

Sector Composition

Rank Sector Weight
1 Technology 25.94%
2 Healthcare 24.16%
3 Consumer Discretionary 13.75%
4 Miscellaneous 13.01%
5 Financials 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AAPL icon
1
Apple
AAPL
$4.7T
$24.7M 7.29%
583,288
-6,316
-1% -$264K
ON icon
2
ON Semiconductor
ON
$28.7B
$21.2M 6.27%
1,013,293
-198,632
-16% -$4.05M
MSFT icon
3
Microsoft
MSFT
$3.71T
$19.6M 5.78%
228,862
-2,551
-1% -$209K
BFH icon
4
Bread Financial
BFH
$4.22B
$17.7M 5.24%
87,666
+229
+0.3% +$42.4K
GILD icon
5
Gilead Sciences
GILD
$186B
$15.8M 4.67%
220,613
-3,534
-2% -$268K
RUSHA icon
6
Rush Enterprises Class A
RUSHA
$5.93B
$12.8M 3.78%
850,541
UNH icon
7
UnitedHealth
UNH
$355B
$12.7M 3.76%
57,760
-939
-2% -$199K
CE icon
8
Celanese
CE
$4.91B
$11.8M 3.48%
109,880
+545
+0.5% +$57.9K
MCK icon
9
McKesson
MCK
$106B
$10.9M 3.22%
69,947
-1,009
-1% -$149K
BMY icon
10
Bristol-Myers Squibb
BMY
$136B
$10.7M 3.16%
174,575
-2,594
-1% -$162K
FHI icon
11
Federated Hermes
FHI
$4.68B
$10.4M 3.09%
289,401
-2,485
-0.9% -$80.5K
GLD icon
12
SPDR Gold Trust
GLD
$149B
$10.2M 3.02%
82,735
+105
+0.1% +$12.7K
LCI
13
DELISTED
Lannett Company, Inc.
LCI
$10M 2.97%
108,284
-5,434
-5% -$530K
HBI
14
DELISTED
Hanesbrands
HBI
$9.95M 2.94%
475,778
-7,359
-2% -$157K
MCHP icon
15
Microchip Technology
MCHP
$40.1B
$8.54M 2.52%
194,296
-3,334
-2% -$151K
DD icon
16
DuPont de Nemours
DD
$17.7B
$8.18M 2.42%
45,376
-784
-2% -$141K
BIIB icon
17
Biogen
BIIB
$32.5B
$7.86M 2.32%
24,682
+135
+0.5% +$43.3K
CCJ icon
18
Cameco
CCJ
$44B
$7.85M 2.32%
850,562
-14,696
-2% -$138K
CELG
19
DELISTED
Celgene Corp
CELG
$7.32M 2.16%
70,101
-1,354
-2% -$153K
OLED icon
20
Universal Display
OLED
$3.78B
$7.29M 2.15%
42,240
-195
-0.5% -$31.1K
DAL icon
21
Delta Air Lines
DAL
$52.5B
$7.15M 2.11%
127,750
-2,395
-2% -$125K
PHM icon
22
Pultegroup
PHM
$23.8B
$6.66M 1.97%
+200,410
New +$6.22M
THO icon
23
Thor Industries
THO
$4B
$6.56M 1.94%
+43,545
New +$6.05M
CTSH icon
24
Cognizant
CTSH
$28.2B
$6.48M 1.92%
91,275
-945
-1% -$69.1K
GMLP
25
DELISTED
Golar LNG Partners LP
GMLP
$5.77M 1.7%
253,035
-400
-0.2% -$8.77K

Similar funds

Muhlenkamp & Co's Q4 2017 Portfolio in Review

As of Q4 2017, Muhlenkamp & Co held 80 positions worth $338M, up 6.6% from $318M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Muhlenkamp & Co's Q4 2017 filing shows 5 new, 6 increased, 42 reduced and 7 closed positions. Its largest new stake was Pultegroup: 200,410 shares worth $6.66M. The largest sale was ON Semiconductor, an estimated $4.05M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Muhlenkamp & Co's largest Q4 2017 buy was Pultegroup: 200,410 shares worth $6.66M.
  • Muhlenkamp & Co added most to Celanese in Q4 2017, an estimated $57.9K increase.
  • Muhlenkamp & Co's biggest Q4 2017 reduction was ON Semiconductor, cutting an estimated $4.05M.
  • Muhlenkamp & Co fully exited Dynagas LNG Partners in Q4 2017, selling an estimated $2.77M.
  • Muhlenkamp & Co's ten largest holdings make up 47% of its $338M portfolio in Q4 2017.
  • Muhlenkamp & Co opened 5 new positions and closed 7 in Q4 2017.
  • Muhlenkamp & Co's portfolio value rose 6.6% quarter-over-quarter to $338M.

Based on Muhlenkamp & Co's 13F filing for Q4 2017, filed 14 Feb 2018.